TetraLogic Pharmaceuticals TLOG Stock
TetraLogic Pharmaceuticals Price Chart
TetraLogic Pharmaceuticals TLOG Financial and Trading Overview
| TetraLogic Pharmaceuticals stock price | 0.0001 USD |
| Previous Close | 0.0001 USD |
| Open | 0.0001 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0001 - 0.0001 USD |
| 52 Week Range | 0.0001 - 0.005 USD |
| Volume | 3.11K USD |
| Avg. Volume | 858 USD |
| Market Cap | 458.72K USD |
| Beta (5Y Monthly) | 3.295422 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
TLOG Valuation Measures
| Enterprise Value | 24.95M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.18 |
Trading Information
TetraLogic Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 3.295422 |
| 52-Week Change | -98.00000000000000000000000000000000% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.005 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.0001 USD |
| 200-Day Moving Average | 0.0004435 USD |
TLOG Share Statistics
| Avg. Volume (3 month) | 858 USD |
| Avg. Daily Volume (10-Days) | 831 USD |
| Shares Outstanding | 24.47M |
| Float | 21.77M |
| Short Ratio | 4.39 |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.016% |
| Shares Short | 1.18M |
| Short % of Float | 7.12% |
| Short % of Shares Outstanding | 4.76% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2015 |
| Most Recent Quarter (mrq) | September 30, 2016 |
| Next Fiscal Year End | December 31, 2016 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -19.59% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -21140180 USD |
| Net Income Avi to Common (ttm) | -40718456 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.89M USD |
| Total Cash Per Share (mrq) | 0.24 USD |
| Total Debt (mrq) | 30.83M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.478 |
| Book Value Per Share (mrq) | -1.249 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -23881276 USD |
| Levered Free Cash Flow (ttm) | -5197156 USD |
Profile of TetraLogic Pharmaceuticals
| Country | United States |
| State | PA |
| City | Malvern |
| Address | 343 Phoenixville Pike |
| ZIP | 19355 |
| Phone | 610 889 9900 |
| Website | https://www.tetralogicpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 29 |
TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to apoptosis or cell-death in damaged cells. SHAPE is its proprietary histone deacetylase inhibitor for topical use for the treatment of early-stage cutaneous T-cell lymphoma. TetraLogic Pharmaceuticals Corporation has research collaboration with Walter and Eliza Hall Institute of Medical Research to examine SMAC-mimetics, including birinapant in the treatment of infectious disease. The company was formerly known as Gentara Corporation and changed its name to TetraLogic Pharmaceuticals Corporation in January 2006. TetraLogic Pharmaceuticals Corporation was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Q&A For TetraLogic Pharmaceuticals Stock
What is a current TLOG stock price?
TetraLogic Pharmaceuticals TLOG stock price today per share is 0.0001 USD.
How to purchase TetraLogic Pharmaceuticals stock?
You can buy TLOG shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for TetraLogic Pharmaceuticals?
The stock symbol or ticker of TetraLogic Pharmaceuticals is TLOG.
Which industry does the TetraLogic Pharmaceuticals company belong to?
The TetraLogic Pharmaceuticals industry is Biotechnology.
How many shares does TetraLogic Pharmaceuticals have in circulation?
The max supply of TetraLogic Pharmaceuticals shares is 4.59B.
What is TetraLogic Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
TetraLogic Pharmaceuticals PE Ratio is now.
What was TetraLogic Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
TetraLogic Pharmaceuticals EPS is -0.01 USD over the trailing 12 months.
Which sector does the TetraLogic Pharmaceuticals company belong to?
The TetraLogic Pharmaceuticals sector is Healthcare.
TetraLogic Pharmaceuticals TLOG included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite Total Return I XCMP | 21356.17 USD — |
+0.87
|
— — | 20988.36 USD — | 21425.55 USD — | — - | — — |
- {{ link.label }} {{link}}